Replies to post #290274 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

Ipix is a Stockholm syndrome situation for many.

[MinnieM]

Yep... that other company hasn't had a single clinical trial in all of it's existence. Pure fluff with nothing to back it up. Has nothing to do with this company other than Leo spent a few years as a CFO there over 10 years ago. I sure understand why he left them.

Dr Menon's CRO, Kard did lab work for them and he was hired as a CMO for a period of time.

Neither of them was in a decision making position. Leo's track record of moving trials forward is quite impressive when you try to compare him to the decision makers of the other company.

This company has been moving forward with clinical trials.
A search of the other has zero trials.

As CTIX: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=



As IPIX: https://clinicaltrials.gov/ct2/results?cond=&term=%22innovation+pharmaceuticals%22&cntry=&state=&city=&dist=&Search=Search



False comparison... not only does the other company have ZERO clinical trials, this one has two that are ph3 ready.

And, a couple of labs researching covid found enough data on Brilacidin to contact the company for testing against COVID.

Brilacidin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=brilacidin&oq=br

Kevetrin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=kevetrin&btnG=

Lack of sufficient funds has been the killer here. Not the science.